Going Public? For Life Sciences Companies, Pivoting in a Down Market | Troutman Pepper
As part of their growth strategy, private biotech and pharmaceutical companies often seek to raise capital through initial public offerings (IPOs). In addition to raising capital, an...
Source: jdsupra.com